{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "64-year-old female diagnosed with adenocarcinoma of the lung with brain and pleural metastases and an activating EGFR mutation (common Exon 19 deletion).",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34",
              "label": "adenocarcinoma of the lung",
              "status": "active"
            },
            {
              "code": "C79.31",
              "label": "brain metastases",
              "status": "active"
            },
            {
              "code": "C79.2",
              "label": "pleural metastases",
              "status": "active"
            }
          ],
          "genetic_info": [
            {
              "gene": "EGFR",
              "mutation": "Exon 19 deletion",
              "effect": "activating"
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Treatment with afatinib was started (40 mg daily).",
        "clinical_data": {
          "medications": [
            {
              "drug": "Afatinib",
              "dosage": "40 mg",
              "frequency": "daily",
              "modality": "oral",
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Afatinib dosage reduced to 30 mg daily due to grade 3 rash and diarrhea.",
        "clinical_data": {
          "medications": [
            {
              "drug": "Afatinib",
              "dosage": "30 mg",
              "frequency": "daily",
              "modality": "oral",
              "indication": "cancer",
              "start_date": null,
              "end_date": null
            }
          ],
          "diagnoses": [
            {
              "code": "R21",
              "label": "Rash",
              "status": "active",
              "onset_date": null
            },
            {
              "code": "R19.7",
              "label": "Diarrhea",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "Clinically relevant tumor progression after 8 months, with hemorrhagic and malignant pleural effusion. Regular thoracentesis performed.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C78.2",
              "label": "Secondary malignant neoplasm of pleura",
              "status": "active"
            }
          ],
          "procedures": [
            {
              "name": "Thoracentesis",
              "approach": "percutaneous",
              "location": "pleural cavity",
              "outcome": "drainage of pleural effusion"
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Re-biopsy and next generation sequencing revealed the known Exon 19 deletion but no treatable resistance mutation.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Biopsy",
              "date": null
            },
            {
              "name": "Next generation sequencing",
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Chemotherapy with cisplatin and pemetrexed was started.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0008677",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C1239844",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "procedures": [
            {
              "name": "C0008653",
              "approach": null,
              "date": null,
              "location": null,
              "performed_by": null,
              "outcome": null
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "Staging after the second cycle of chemotherapy revealed partial remission (Figure 1B).",
        "clinical_data": {
          "procedures": [
            {
              "name": "Chemotherapy",
              "date": null
            }
          ],
          "diagnoses": [
            {
              "code": null,
              "label": "partial remission",
              "status": "active",
              "onset_date": null
            }
          ],
          "imaging": [
            {
              "type": null,
              "body_part": null,
              "modality": null,
              "finding": "partial remission",
              "impression": null,
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "After six cycles of chemotherapy maintenance treatment with pemetrexed was initiated.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0974170",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "procedures": [
            {
              "name": "C0009264",
              "approach": null,
              "date": null,
              "location": null,
              "performed_by": null,
              "outcome": null
            }
          ]
        }
      }
    },
    {
      "id": "N9",
      "label": "Step 9",
      "customData": {
        "node_id": "I",
        "node_step_index": 8,
        "content": "After a few weeks the patient\u2019s performance status worsened and she developed progressive pleural carcinomatosis.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C78.2",
              "label": "Secondary malignant neoplasm of pleura",
              "status": "active"
            }
          ]
        }
      }
    },
    {
      "id": "N10",
      "label": "Step 10",
      "customData": {
        "node_id": "J",
        "node_step_index": 9,
        "content": "Following 15 months of afatinib treatment the patient developed peritoneal carcinomatosis and the rebiopsy revealed a T790M mutation.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C56.9",
              "label": "Peritoneal carcinomatosis",
              "status": "active",
              "onset_date": null
            }
          ],
          "medications": [
            {
              "drug": "C1911359",
              "dosage": null,
              "frequency": null,
              "modality": "oral",
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N11",
      "label": "Step 11",
      "customData": {
        "node_id": "K",
        "node_step_index": 10,
        "content": "A third-line treatment with osimertinib was initiated.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C3888713",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N12",
      "label": "Step 12",
      "customData": {
        "node_id": "L",
        "node_step_index": 11,
        "content": "Six months after osimertinib initiation, the patient was admitted to the hospital with progressive dyspnea caused by a hemorrhagic, malignant pleural effusion, massive pulmonary embolism, and new skin metastases. Malignant cells of the pleural effusion harbored the Exon 19 deletion. Skin metastases revealed adenocarcinoma of the lung without EGFR mutation. No T790M mutation detectable.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0006572",
              "label": "Malignant pleural effusion",
              "status": "active"
            },
            {
              "code": "C0032288",
              "label": "Pulmonary embolism",
              "status": "active"
            },
            {
              "code": "C0242964",
              "label": "Skin metastases",
              "status": "active"
            },
            {
              "code": "C0001637",
              "label": "Adenocarcinoma of the lung",
              "status": "active"
            }
          ],
          "HPI": [
            {
              "progression": "progressive",
              "associated_symptoms": [
                "C0013404"
              ],
              "duration": "6 months"
            }
          ]
        }
      }
    },
    {
      "id": "N13",
      "label": "Step 13",
      "customData": {
        "node_id": "M",
        "node_step_index": 12,
        "content": "Patient in bad general condition (ECOG 3).",
        "clinical_data": {
          "functional_status": [
            {
              "domain": "general",
              "description": "bad general condition",
              "score": "3",
              "scale": "ECOG"
            }
          ]
        }
      }
    },
    {
      "id": "N14",
      "label": "Step 14",
      "customData": {
        "node_id": "N",
        "node_step_index": 13,
        "content": "Following chemotherapy no further thoracentesis was needed, performance status improved.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Thoracentesis",
              "outcome": "No further thoracentesis was needed"
            }
          ],
          "functional_status": [
            {
              "domain": "general",
              "description": "performance status improved"
            }
          ]
        }
      }
    },
    {
      "id": "N15",
      "label": "Step 15",
      "customData": {
        "node_id": "O",
        "node_step_index": 14,
        "content": "After maintenance treatment with pemetrexed, the patient developed a recurrent malignant pleural effusion after a few weeks.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C38.4",
              "label": "Malignant neoplasm of pleura",
              "status": "active"
            }
          ],
          "procedures": [
            {
              "name": "Pemetrexed",
              "approach": "IV",
              "outcome": "recurrent malignant pleural effusion"
            }
          ]
        }
      }
    },
    {
      "id": "N16",
      "label": "Step 16",
      "customData": {
        "node_id": "P",
        "node_step_index": 15,
        "content": "Re-biopsy and next generation sequencing revealed the known L858R mutation, but no other resistance mutations.",
        "clinical_data": {
          "labs": [
            {
              "test": "Next Generation Sequencing",
              "finding": "L858R mutation",
              "flag": "abnormal"
            }
          ]
        }
      }
    },
    {
      "id": "N17",
      "label": "Step 17",
      "customData": {
        "node_id": "Q",
        "node_step_index": 16,
        "content": "After the first cycle of cisplatin and pemetrexed chemotherapy, no further thoracentesis was needed, dyspnea and pain improved.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0008893",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C0858843",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "procedures": [
            {
              "name": "C0042293",
              "approach": null,
              "date": null,
              "location": "thorax",
              "performed_by": null,
              "outcome": null
            }
          ],
          "HPI": [
            {
              "summary": "Dyspnea improved",
              "duration": null,
              "onset": null,
              "progression": null,
              "associated_symptoms": [],
              "alleviating_factors": [],
              "exacerbating_factors": []
            },
            {
              "summary": "Pain improved",
              "duration": null,
              "onset": null,
              "progression": null,
              "associated_symptoms": [],
              "alleviating_factors": [],
              "exacerbating_factors": []
            }
          ]
        }
      }
    },
    {
      "id": "N18",
      "label": "Step 18",
      "customData": {
        "node_id": "R",
        "clinical_data": {}
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Decision to start treatment.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0884189"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Adverse reaction to afatinib requiring dosage adjustment.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0884189",
            "R21",
            "R19.7"
          ],
          "change_type": "deescalation",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Tumor progression and development of pleural effusion.",
        "transition_event": {
          "trigger_type": "progression",
          "trigger_entities": [
            "C34"
          ],
          "change_type": "progression",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Re-biopsy performed to assess resistance mechanisms.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [],
          "change_type": "addition",
          "target_domain": "procedure"
        }
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Decision to initiate chemotherapy.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0008677",
            "C1239844"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Response to chemotherapy.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C0008653"
          ],
          "change_type": "other",
          "target_domain": "imaging"
        }
      }
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "Transition to maintenance therapy.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0974170"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N8",
      "to": "N9",
      "data": {
        "edge_id": "H_to_I",
        "branch_flag": true,
        "content": "Worsening of performance status and progressive pleural carcinomatosis.",
        "transition_event": {
          "trigger_type": "progression",
          "trigger_entities": [
            "C78.2"
          ],
          "change_type": "progression",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N9",
      "to": "N10",
      "data": {
        "edge_id": "I_to_J",
        "branch_flag": true,
        "content": "Development of peritoneal carcinomatosis and detection of T790M mutation.",
        "transition_event": {
          "trigger_type": "progression",
          "trigger_entities": [
            "C56.9"
          ],
          "change_type": "progression",
          "target_domain": "diagnosis"
        }
      }
    }
  ]
}